Uveal melanoma cells are resistant to EZH2 inhibition regardless of BAP1 status

Nat Med. 2016 Jun 7;22(6):577-8. doi: 10.1038/nm.4098.

Authors

Marie Schoumacher^{1

2}, Stéphanie Le Corre^{1

3}, Alexandre Houy^{1

4}, Eskeatnaf Mulugeta^{1

3}, Marc-Henri Stern^{1

4}, Sergio Roman-Roman^{1

2}, Raphaël Margueron^{1

3}

Affiliations

¹ Institut Curie, Paris Sciences et Lettres Research University, Paris, France.
² Department of Translational Research, Paris, France.
³ Institut National de la Santé et de la Recherche Médicale (INSERM) U934-Centre National de Recherche Scientifique (CNRS) Unité Mixte de Recherche (UMR) 3215, Paris, France.
⁴ INSERM U830, Paris, France.

PMID: 27270772
DOI: 10.1038/nm.4098

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Humans
Melanoma*
Tumor Suppressor Proteins
Ubiquitin Thiolesterase
Uveal Neoplasms*

Substances

Tumor Suppressor Proteins
Ubiquitin Thiolesterase

Supplementary concepts

Uveal melanoma